Nectar RHS Komplementar ApS: Financial statements 2025
CVR: 41934530
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Nectar RHS Komplementar ApS (CVR 41934530) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity in the 2025 report amounted to DKK 177,416. The solvency ratio was 82.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK 38,849
- Equity
- DKK 177,416
- Total Assets
- DKK 215,688
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5 t. | 39 t. | 177 t. | 1 |
| 2024 | - | -5 t. | 58 t. | 139 t. | 1 |
| 2023 | - | -5 t. | 15 t. | 80 t. | 1 |
| 2022 | - | -13 t. | 10 t. | 65 t. | 0 |
| 2021 | - | -5 t. | 16 t. | 56 t. | 0 |
How creditworthy is Nectar RHS Komplementar ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Nectar RHS Komplementar ApS has published its annual report for 2024. Gross profit came to DKK -5,000, and the net result was DKK 58,075.
About Nectar RHS Komplementar ApS
Nectar RHS Komplementar ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Bjørk Krogshave. The company is owned by PharmaService I/S and Nectar Invest A/S. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity in the 2025 report amounted to DKK 177,416.